...
首页> 外文期刊>International ophthalmology >Comparison of graft survival following penetrating keratoplasty and Descemet’s stripping endothelial keratoplasty in eyes with a glaucoma drainage device
【24h】

Comparison of graft survival following penetrating keratoplasty and Descemet’s stripping endothelial keratoplasty in eyes with a glaucoma drainage device

机译:渗透角膜术后渐进式植入物的比较和脱硫剥离眼睛剥离眼睛剥离内皮角膜术与青光眼引流装置

获取原文
获取原文并翻译 | 示例

摘要

Abstract Purpose To compare corneal graft survival rates after penetrating keratoplasty (PK) and Descemet’s stripping endothelial keratoplasty (DSEK) in patients with a glaucoma drainage device (GDD) or medically managed glaucoma. Methods A retrospective chart review was conducted on consecutive patients who underwent primary PK or primary DSEK. Inclusion criteria consisted of eyes with a diagnosis of glaucoma prior to corneal transplantation and a minimum of 6?months of follow-up. Graft failure was defined as an edematous cornea with failure to maintain deturgescence lasting beyond a period of 1?month of intense steroid therapy or vascularization and scarring resulting in irreversible loss of central graft clarity. Corneal graft survival was calculated using Kaplan–Meier survival analysis. Patients were divided into four groups: GDD-PK, GDD-DSEK, medical-PK and medical-DSEK. Results Fifty-six eyes of 56 patients were identified as meeting inclusion criteria. Among eyes with a GDD, there was no difference in the proportion of failures between PK grafts (48%) and DSEK grafts (50%) ( p ?=?0.90). Failure occurred earlier in DSEK recipients compared to PK recipients, 5.82?±?6.77?months versus 14.40?±?7.70?months, respectively ( p ?=?0.04). A Kaplan–Meier analysis did not identify a difference between the four groups with respect to graft failure ( p ?=?0.52). Conclusion There is no significant difference in graft survival rates between medically and surgically treated glaucoma patients for either PK or DSEK grafts. In patients with GDD, graft failure occurs earlier in DSEK compared to PK.
机译:摘要目的,用于比较渗透角膜膜(PK)和Descemet剥离患者的渗透角膜术后(PK)和Descemet剥离内皮角膜术(DSEK)患者患者患有青光眼引流装置(GDD)或医学管理的青光眼。方法对接受初级PK或原发性DSEK的连续患者进行了回顾性图表审查。纳入标准由眼部移植前的诊断有青光眼的眼睛,最少6个月的后续行动。接枝衰竭被定义为一种具有未持久性持久的水肿角膜,超过1?持续的类固醇治疗或血管化和疤痕导致中央移植透明度不可逆转的损失。使用Kaplan-Meier生存率分析计算角膜移植存活。患者分为四组:GDD-PK,GDD-DSEK,医疗PK和医疗 - DSEK。结果56名患者的56只患者被确定为会议纳入标准。在具有GDD的眼中,PK移植物(48%)和DSEK移植物(50%)之间的故障比例没有差异(P?= 0.90)。与PK接收者相比,DSE收件人之前发生了失败,5.82?±6.77?月与14.40?±7.70?几个月(p?= 0.04)。 Kaplan-Meier分析没有识别四组相对于移植物失败之间的差异(p?= 0.52)。结论医学和手术治疗的青光眼患者对PK或DSEK移植物之间的移植存活率没有显着差异。在GDD患者中,与PK相比,DSEK的接枝失败发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号